Our offering
Supporting access to therapies for rare indications is crucial in navigating the current trends in rare disease treatment approval. Our expertise in the European healthcare market access and specialized market access services ensures successful commercialisation of orphan drugs. With insights into emerging trends in orphan drug approvals, we provide expert consultancy for rare disease drug access.
Flexible market access resourcing for lean teams
We work closely with you to develop tailored market entry strategies, ensuring your rare disease product reaches its target audience effectively.
Key payer & KOL relationships
We leverage our extensive network to facilitate interactions and create partnerships with key payers and key healthcare providers.
Country level access support
We assist in securing fair and sustainable reimbursement for your products at country level, making them accessible to those who need them most.
Commercialization
We develop tailored market strategies to enhance the commercialization of rare disease therapies. Our approach ensures efficient access and long-term success in the healthcare market.
ENTRI key services
- European and in-country market assessment and entry strategy
- Local stakeholder mapping, engagement and insight generation
- Early identification and engagement of key opinion leaders
- Collaboration with patient organisations to integrate patient perspectives
- Pricing, reimbursement and market access strategy
- Assessment and development of managed entry agreements and deal structures
- HTA, payer engagement and local evidence planning
- Selection and coordination of local partners
- Launch readiness and practical in-country implementation
- Local data and evidence generation, including EHR data, RWE, registries, biobanks and surveys
- Digital engagement strategies and tailored communication solutions
- Flexible senior-level support for specific projects or internal resource gaps
Our ENTRI experts
Discover seamless market entry for rare disease treatments with our expert guidance, ensuring maximum impact and accessibility.